SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950124-05-004578
Filing Date
2005-08-01
Accepted
2005-08-01 15:39:19
Documents
12
Period of Report
2005-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v11186e8vk.htm 8-K 26683
2 EXHIBIT 10.1 v11186exv10w1.txt EX-10.1 15499
3 EXHIBIT 10.2 v11186exv10w2.txt EX-10.2 90599
4 EXHIBIT 10.3 v11186exv10w3.txt EX-10.3 28664
5 EXHIBIT 10.4 v11186exv10w4.txt EX-10.4 4163
6 EXHIBIT 10.5 v11186exv10w5.txt EX-10.5 2935
7 EXHIBIT 10.6 v11186exv10w6.txt EX-10.6 2985
8 EXHIBIT 10.7 v11186exv10w7.txt EX-10.7 2988
9 EXHIBIT 10.8 v11186exv10w8.txt EX-10.8 2733
10 EXHIBIT 10.9 v11186exv10w9.txt EX-10.9 2629
11 EXHIBIT 10.10 v11186exv10w10.txt EX-10.10 2634
12 EXHIBIT 10.11 v11186exv10w11.txt EX-10.11 2693
  Complete submission text file 0000950124-05-004578.txt   186752
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 05988235
SIC: 2834 Pharmaceutical Preparations